Found: 9
Select item for more details and to access through your institution.
A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 5, p. 1048, doi. 10.1038/mt.2014.22
- By:
- Publication type:
- Article
Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 1, p. 199, doi. 10.1038/mt.2008.228
- By:
- Publication type:
- Article
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 4, p. 359, doi. 10.1038/sj.cgt.7700784
- By:
- Publication type:
- Article
Production of Bioactive Soluble Interleukin-15 in Complex with Interleukin-15 Receptor Alpha from a Conditionally-Replicating Oncolytic HSV-1.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0081768
- By:
- Publication type:
- Article
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 1, p. 45, doi. 10.1002/pbc.24117
- By:
- Publication type:
- Article
Increased efficacy of an interleukin-12-secreting herpes simplex virus in a syngeneic intracranial murine glioma model.
- Published in:
- Neuro-Oncology, 2005, v. 7, n. 3, p. 213, doi. 10.1215/S1152851705000074
- By:
- Publication type:
- Article
Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Preclinical Evaluation of Oncolytic ▵ γ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases.
- Published in:
- International Journal of Breast Cancer, 2012, p. 1, doi. 10.1155/2012/628697
- By:
- Publication type:
- Article
Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response.
- Published in:
- Viruses (1999-4915), 2009, v. 1, n. 3, p. 510, doi. 10.3390/v1030510
- By:
- Publication type:
- Article